Sign in
TerminatedNo phase

Open-Label Prospective Study Comparing Long-Term Outcome With or Without HFNC in Patients With Stable Hypercapnic COPD

Key facts

Who runs it
Turku University Hospital
Where
Finland1 site in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
3 people enrolled
Started
21 Apr 2022
Ended
30 Apr 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • HFNC Airvo
  • Standard care
Record updated
29 December 2025
Why it stopped
It was not possible to achieve recruitment target

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The aims of the study are to compare long-term one-year outcome with or without AirvoTM in stabile hypercapnic COPD patients, who are non-compliant to NIV after an acute exacerbation of COPD.

The 2 groups in the trial

  • AirvoExisting treatment, for comparison

    Patients allocated to use Airvo device

    Treatment: HFNC Airvo

  • ControlPlacebo, for comparison

    Patients not using Airvo, standard care

    Treatment: Standard care

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Open-Label Prospective Study Comparing Long-Term Outcome With or Without High-flow Nasal Cannula AirvoTM in Patients With Stable Hypercapnic COPD
Record updated
29 December 2025